News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Valeant Pharmaceuticals International
NEWS
IN THE PRESS
NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Bio NC
10 Biotech Stocks that Could Blow Up in Q3
July 6, 2016
·
3 min read
Business
AstraZeneca PLC, Valeant and LEO Pharma Shuffle Dermatology Rights, Potential $1 Billion in Sales at Stake
July 1, 2016
·
3 min read
Business
Ex-Valeant CEO’s Pay Structure May Have Increased Dangerous Risk-Taking, Stanford University Study Says
June 10, 2016
·
1 min read
Business
Valeant Scrambles to Restructure Deal with Walgreens
June 9, 2016
·
2 min read
Business
Former Valeant CEO Nabs $9+ Million Severance Deal and Consulting Role
June 1, 2016
·
3 min read
Deals
Embattled Valeant Reportedly Spurned a Takeover Offer from Takeda-TPG
May 27, 2016
·
2 min read
Business
Valeant’s New CEO Criticized By Man Who Succeeded Him at Perrigo
May 13, 2016
·
2 min read
Genetown
Valeant: Unsealed Ackman Emails Should Terrify Bulls
May 9, 2016
·
1 min read
Investors Concerned as Endo Pharma Mimics the Path of Valeant
May 9, 2016
·
3 min read
IN THE PRESS
Business
Pharming Group Completes Transaction With Valeant On Redemption Of All North American Rights RUCONEST
December 8, 2016
·
2 min read
Drug Development
Valeant Announces Phase 3 Results For Psoriasis Treatment IDP-118
December 8, 2016
·
3 min read
Business
Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan And Relistor
November 30, 2016
·
2 min read
Policy
Valeant Comments On Issued Philidor Criminal Charges
November 17, 2016
·
1 min read
Bill Ackman Says Valeant Might Change Its Name To Fix Its Reputation
November 11, 2016
·
1 min read
Business
Orexigen Announces Commercialization And Distributorship Agreement With Valeant For Contrave (Naltrexone HCL / Bupropion HCL Extended Release) In Australia And New Zealand
November 9, 2016
·
17 min read
Deals
Valeant Divests Paragon Holdings to Settle FTC Antitrust Charges
November 8, 2016
·
1 min read
Deals
Debt-Ridden Valeant Exploring Sale of Its Eye Surgery Equipment Biz, Deal Could Bring in $2.5 Billion
November 3, 2016
·
1 min read
Policy
Investors Behind Sprout Accuse Valeant of Bungling Marketing of Female Libido Drug
November 3, 2016
·
1 min read
Valeant Comments On Press Report Regarding Its Gastroenterology Business Unit
November 2, 2016
·
1 min read
